[{"Assets_0_Q2_USD":802783000.0,"CommonStockSharesOutstanding_0_Q2_shares":89207455.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-153877000.0,"NetIncomeLoss_2_Q2_USD":-140667000.0,"NetIncomeLoss_1_Q2_USD":-66514000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":81806000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":79685000.0,"StockholdersEquity_0_Q2_USD":356573000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]